Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia

Free Radical Biology and Medicine

Volumn 49, Issue 3, 2010, Pages 493-500

  Sandrim, Valeria C ^a   Montenegro, Marcelo F ^b   Palei, Ana C T ^c   Metzger, Ingrid F ^b   Sertorio, Jonas T C ^b   Cavalli, Ricardo C ^b   Tanus Santos, Jose E ^b  

^a Santa Casa de Belo Horizonte   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Nitric oxide; Nitrite; Preeclampsia

Indexed keywords

CERULOPLASMIN; HEMOGLOBIN; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; BIOAVAILABILITY; BLOOD; METABOLISM; PREGNANCY;

ADULT; BIOLOGICAL AVAILABILITY; CERULOPLASMIN; FEMALE; HEMOGLOBINS; HUMANS; NITRIC OXIDE; NITRITES; PRE-ECLAMPSIA; PREGNANCY;

EID: 77954144348     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.05.012     Document Type: Article

References (62)

1. Sladek S.M., Magness R.R., Conrad K.P. Nitric oxide and pregnancy. Am. J. Physiol. 1997, 272:R441-R463.
2. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329:2002-2012.
3. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
4. Mayer B., Pfeiffer S., Schrammel A., Koesling D., Schmidt K., Brunner F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 1998, 273:3264-3270.
5. Schmidt H.H., Hofmann H., Schindler U., Shutenko Z.S., Cunningham D.D., Feelisch M. No.NO from NO synthase. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14492-14497.
6. Williams D.J., Vallance P.J., Neild G.H., Spencer J.A., Imms F.J. Nitric oxide-mediated vasodilation in human pregnancy. Am. J. Physiol. 1997, 272:H748-H752.
7. Weiner C.P., Knowles R.G., Moncada S. Induction of nitric oxide synthases early in pregnancy. Am. J. Obstet. Gynecol. 1994, 171:838-843.
8. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 1994, 171:944-948.
9. Choi J.W., Im M.W., Pai S.H. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann. Clin. Lab. Sci. 2002, 32:257-263.
10. Sandrim V.C., Palei A.C., Metzger I.F., Gomes V.A., Cavalli R.C., Tanus-Santos J.E. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 2008, 52:402-407.
11. Savvidou M.D., Hingorani A.D., Tsikas D., Frolich J.C., Vallance P., Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361:1511-1517.
12. Kukor Z., Meszaros G., Hertelendy F., Toth M. Calcium-dependent nitric oxide synthesis is potently stimulated by tetrahydrobiopterin in human primordial placenta. Placenta 1996, 17:69-73.
13. Sandrim V.C., de Syllos R.W., Lisboa H.R., Tres G.S., Tanus-Santos J.E. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 2007, 16:348-355.
14. Sandrim V.C., Palei A.C., Cavalli R.C., Araujo F.M., Ramos E.S., Duarte G., Tanus-Santos J.E. eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 2008, 9:1467-1473.
15. Li H., Gu B., Zhang Y., Lewis D.F., Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005, 26:210-217.
16. Gladwin M.T., Crawford J.H., Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 2004, 36:707-717.
17. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 2002, 8:1383-1389.
18. Kato G.J., Gladwin M.T. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 2008, 300:2638-2646.
19. Rother R.P., Bell L., Hillmen P., Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005, 293:1653-1662.
20. Anonymous Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000, 183:S1-S22.
21. Pelletier M.M., Kleinbongard P., Ringwood L., Hito R., Hunter C.J., Schechter A.N., Gladwin M.T., Dejam A. The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions. Free Radic. Biol. Med. 2006, 41:541-548.
22. Nagassaki S., Sertorio J.T.C., Metzger I.F., Bem A.F., Rocha J.B.T., Tanus-Santos J.E. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic. Biol. Med. 2006, 41:1044-1049.
23. Dejam A., Hunter C.J., Pelletier M.M., Hsu L.L., Machado R.F., Shiva S., Power G.G., Kelm M., Gladwin M.T., Schechter A.N. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005, 106:734-739.
24. Metzger I.F., Souza-Costa D.C., Marroni A.S., Nagassaki S., Desta Z., Flockhart D.A., Tanus-Santos J.E. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet. Genomics 2005, 15:565-570.
25. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., Tanus-Santos J.E. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb. Res. 2005, 115:375-379.
26. Yang B.K., Vivas E.X., Reiter C.D., Gladwin M.T. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 2003, 37:1-10.
27. Dias-Junior C.A., Gladwin M.T., Tanus-Santos J.E. Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. Free Radic. Biol. Med. 2006, 41:1764-1770.
28. Nagababu E., Rifkind J.M. Measurement of plasma nitrite by chemiluminescence without interference of S-, N-nitroso and nitrated species. Free Radic. Biol. Med. 2007, 42:1146-1154.
29. MacArthur P.H., Shiva S., Gladwin M.T. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 851:93-105.
30. Montenegro M.F., Pessa L.R., Gomes V.A., Desta Z., Flockhart D.A., Tanus-Santos J.E. Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. Basic Clin. Pharmacol. Toxicol. 2009, 104:400-407.
31. Wang X., Tanus-Santos J.E., Reiter C.D., Dejam A., Shiva S., Smith R.D., Hogg N., Gladwin M.T. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11477-11482.
32. Greenberg L.A., Lester D., Haggard H.W. The reaction of hemoglobin with nitrite. J. Biol. Chem. 1943, 280:665-673.
33. Llurba E., Gratacos E., Martin-Gallan P., Cabero L., Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic. Biol. Med. 2004, 37:557-570.
34. Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet 1990, 336:1030-1032.
35. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Godecke A., Schrader J., Schulz R., Heusch G., Schaub G.A., Bryan N.S., Feelisch M., Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med. 2003, 35:790-796.
36. Kelm M., Preik-Steinhoff H., Preik M., Strauer B.E. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc. Res. 1999, 41:765-772.
37. Gladwin M.T., Schechter A.N., Kim-Shapiro D.B., Patel R.P., Hogg N., Shiva S., Cannon R.O., Kelm M., Wink D.A., Espey M.G., Oldfield E.H., Pluta R.M., Freeman B.A., Lancaster J.R., Feelisch M., Lundberg J.O. The emerging biology of the nitrite anion. Nat. Chem. Biol. 2005, 1:308-314.
38. Lundberg J.O., Weitzberg E., Gladwin M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 2008, 7:156-167.
39. Shiva S., Wang X., Ringwood L.A., Xu X., Yuditskaya S., Annavajjhala V., Miyajima H., Hogg N., Harris Z.L., Gladwin M.T. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol. 2006, 2:486-493.
40. Kristensen K., Wide-Swensson D., Lindstrom V., Schmidt C., Grubb A., Strevens H. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol. Obstet. Invest. 2009, 67:275-280.
41. Orhan H.G., Ozgunes H., Beksac M.S. Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. Clin. Biochem. 2001, 34:505-506.
42. Bernardi F., Constantino L., Machado R., Petronilho F., Dal-Pizzol F. Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. J. Obstet. Gynaecol. Res. 2008, 34:957-963.
43. Mayret-Mesquiti M., Perez-Mendez O., Rodriguez M.E., Fortoul T.I., Gorocica P., Bernal-Alcantara D., Montano L.F., Alvarado-Vasquez N. Hypertriglyceridemia is linked to reduced nitric oxide synthesis in women with hypertensive disorders of pregnancy. Hypertens. Pregnancy 2007, 26:423-431.
44. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8757-8761.
45. Nakai K., Ohta T., Sakuma I., Akama K., Kobayashi Y., Tokuyama S., Kitabatake A., Nakazato Y., Takahashi T.A., Sadayoshi S. Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins. J. Cardiovasc. Pharmacol. 1996, 28:115-123.
46. Gladwin M.T., Sachdev V., Jison M.L., Shizukuda Y., Plehn J.F., Minter K., Brown B., Coles W.A., Nichols J.S., Ernst I., Hunter L.A., Blackwelder W.C., Schechter A.N., Rodgers G.P., Castro O., Ognibene F.P. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 2004, 350:886-895.
47. Lin E.E., Rodgers G.P., Gladwin M.T. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease. Curr. Hematol. Rep. 2005, 4:117-125.
48. Villers M.S., Jamison M.G., De Castro L.M., James A.H. Morbidity associated with sickle cell disease in pregnancy. Am. J. Obstet. Gynecol. 2008, 199:125.
49. Tsaras G., Owusu-Ansah A., Boateng F.O., Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am. J. Med. 2009, 24:24.
50. Balla G., Vercellotti G.M., Eaton J.W., Jacob H.S. Iron loading of endothelial cells augments oxidant damage. J. Lab. Clin. Med. 1990, 116:546-554.
51. Scalera F. Intracellular glutathione and lipid peroxide availability and the secretion of vasoactive substances by human umbilical vein endothelial cells after incubation with TNF-alpha. Eur. J. Clin. Invest. 2003, 33:176-182.
52. Lavrovsky Y., Schwartzman M.L., Levere R.D., Kappas A., Abraham N.G. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5987-5991.
53. Porto B.N., Alves L.S., Fernandez P.L., Dutra T.P., Figueiredo R.T., Graca-Souza A.V., Bozza M.T. Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. J. Biol. Chem. 2007, 282:24430-24436.
54. Appleton S.D., Marks G.S., Nakatsu K., Brien J.F., Smith G.N., Graham C.H., Lash G.E. Effects of hypoxia on heme oxygenase expression in human chorionic villi explants and immortalized trophoblast cells. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H853-H858.
55. Knapen M.F., Peters W.H., Mulder T.P., Merkus H.M., Jansen J.B., Steegers E.A. Plasma glutathione S-transferase Pi 1-1 measurements in the study of hemolysis in hypertensive disorders of pregnancy. Hypertens. Pregnancy 1999, 18:147-156.
56. Nagel R.L., Gibson Q.H. The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J. Biol. Chem. 1971, 246:69-73.
57. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 2001, 409:198-201.
58. Gilbert J.S., Ryan M.J., LaMarca B.B., Sedeek M., Murphy S.R., Granger J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H541-H550.
59. Hladunewich M., Karumanchi S.A., Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin. J. Am. Soc. Nephrol. 2007, 2:543-549. (Electronic publication 2007 Apr 2004).
60. Hausladen A., Rafikov R., Angelo M., Singel D.J., Nudler E., Stamler J.S. Assessment of nitric oxide signals by triiodide chemiluminescence. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:2157-2162.
61. Samouilov A., Zweier J.L. Development of chemiluminescence-based methods for specific quantitation of nitrosylated thiols. Anal. Biochem. 1998, 258:322-330.
62. Marley R., Feelisch M., Holt S., Moore K. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 2000, 32:1-9.